Donna Ferriero, who is internationally recognized as an expert in the care of newborns and children with neurological disabilities, has been named chair of the Department of Pediatrics and physician-in-chief of UCSF Benioff Children's Hospital.
April 15, 2011
Dozens of faculty, medical residents, postdoctoral fellows, and graduate students from UCSF presented their latest advances and discoveries in the fields of neurology and neurosurgery during international meetings in Honolulu and Denver.
April 15, 2011
A team of researchers at UCSF has developed a simple screening tool – a question – to identify people with HIV who have neurological complications related to their infections.
April 08, 2011
Michael Weiner, who is a professor at UCSF and an investigator of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), accepted the 2011 Ronald and Nancy Reagan Research Award from the Alzheimer’s Association on behalf of the ADNI.
February 24, 2011
Among those cheering the recent opening of the new stem cell science building at UCSF were two patient advocates who have a personal connection to advancing the field of regenerative medicine.
January 24, 2011
A documentary debuting today shows how UCSF researchers are using innovative multidisciplinary treatment strategies for patients living with Parkinson’s disease.
January 04, 2011
Parkinson’s disease researcher Robert Nussbaum, a human geneticist and neuroscientist at UCSF, has been named to receive the prestigious Klaus Joachim Zülch Neuroscience Prize for 2011.
November 19, 2010
UCSF’s Stanley Prusiner, who received the National Medal of Science from President Barack Obama on Wednesday, urges today’s students to become the next generation of scientists.
October 04, 2010
Synuclein is a protein that can cause Parkinson’s disease, although it is not clear how. UCSF researcher Robert Edwards, MD, now has discovered that synuclein can affect signal transmission between nerve cells long before disease symptoms arise.
August 30, 2010
UCSF is co-sponsoring a symposium on September 27 and 28 to provide scientists and physicians with the “nuts and bolts” of translating stem cell science into cell-based products for clinical trials.